HEREN HEALTH CO., LTD. Financials Heren Health Co., Ltd.
Equities
300550
CNE100002D53
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.4 CNY | -2.44% |
|
-3.97% | -30.62% |
| Apr. 25 | Heren Health Co., Ltd Proposes Final Dividend for 2023 | CI |
| Apr. 24 | Heren Health Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 4,344 | 3,269 | 3,400 | 3,405 | 4,154 | 3,936 |
| Enterprise Value (EV) 1 | 4,065 | 2,950 | 2,717 | 2,837 | 3,700 | 3,429 |
| P/E ratio | 105 x | 77.4 x | 68.9 x | 98.8 x | -49.4 x | 99.9 x |
| Yield | 0.14% | 0.2% | 0.2% | 0.16% | - | - |
| Capitalization / Revenue | 11.1 x | 7.41 x | 7.48 x | 7.34 x | 11.5 x | 8.96 x |
| EV / Revenue | 10.4 x | 6.69 x | 5.98 x | 6.11 x | 10.3 x | 7.81 x |
| EV / EBITDA | 81.1 x | 60.6 x | 58.5 x | 83.5 x | -42.2 x | 44 x |
| EV / FCF | 122 x | 120 x | -337 x | -15.6 x | -70.3 x | 95.2 x |
| FCF Yield | 0.82% | 0.83% | -0.3% | -6.41% | -1.42% | 1.05% |
| Price to Book | 7.94 x | 5.29 x | 3.1 x | 3.01 x | 3.99 x | 3.56 x |
| Nbr of stocks (in thousands) | 227,999 | 229,920 | 265,901 | 264,995 | 262,739 | 262,560 |
| Reference price 2 | 19.05 | 14.22 | 12.79 | 12.85 | 15.81 | 14.99 |
| Announcement Date | 4/25/19 | 4/26/20 | 4/26/21 | 4/27/22 | 4/26/23 | 4/24/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 391.4 | 441 | 454.7 | 464.2 | 360.3 | 439.3 |
| EBITDA 1 | 50.12 | 48.72 | 46.41 | 33.99 | -87.74 | 77.91 |
| EBIT 1 | 38.54 | 37.29 | 35.51 | 23.68 | -97.56 | 47.05 |
| Operating Margin | 9.85% | 8.46% | 7.81% | 5.1% | -27.08% | 10.71% |
| Earnings before Tax (EBT) 1 | 43.16 | 44.06 | 47.65 | 35.27 | -95.05 | 40.97 |
| Net income 1 | 40.44 | 41.23 | 43.14 | 34.81 | -83.31 | 39.12 |
| Net margin | 10.33% | 9.35% | 9.49% | 7.5% | -23.12% | 8.91% |
| EPS 2 | 0.1822 | 0.1837 | 0.1857 | 0.1300 | -0.3200 | 0.1500 |
| Free Cash Flow 1 | 33.31 | 24.53 | -8.061 | -181.8 | -52.62 | 36.01 |
| FCF margin | 8.51% | 5.56% | -1.77% | -39.17% | -14.6% | 8.2% |
| FCF Conversion (EBITDA) | 66.47% | 50.35% | - | - | - | 46.22% |
| FCF Conversion (Net income) | 82.37% | 59.49% | - | - | - | 92.05% |
| Dividend per Share 2 | 0.0273 | 0.0281 | 0.0250 | 0.0200 | - | - |
| Announcement Date | 4/25/19 | 4/26/20 | 4/26/21 | 4/27/22 | 4/26/23 | 4/24/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 279 | 319 | 682 | 568 | 454 | 507 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | 33.3 | 24.5 | -8.06 | -182 | -52.6 | 36 |
| ROE (net income / shareholders' equity) | 7.2% | 6.96% | 4.79% | 3.03% | -7.65% | 3.67% |
| ROA (Net income/ Total Assets) | 2.94% | 2.46% | 1.76% | 0.96% | -4.14% | 2.05% |
| Assets 1 | 1,374 | 1,678 | 2,445 | 3,626 | 2,013 | 1,906 |
| Book Value Per Share 2 | 2.400 | 2.690 | 4.120 | 4.270 | 3.960 | 4.210 |
| Cash Flow per Share 2 | 1.600 | 1.300 | 1.660 | 1.720 | 1.930 | 2.170 |
| Capex 1 | 17.3 | 17.7 | 63.5 | 76.4 | 37.1 | 24.9 |
| Capex / Sales | 4.43% | 4.02% | 13.95% | 16.46% | 10.31% | 5.66% |
| Announcement Date | 4/25/19 | 4/26/20 | 4/26/21 | 4/27/22 | 4/26/23 | 4/24/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -30.62% | 378M | |
| +5.85% | 32.93B | |
| +20.16% | 7.94B | |
| +30.81% | 4.19B | |
| -25.95% | 2.8B | |
| -19.96% | 1.38B | |
| -31.87% | 1.17B | |
| +8.02% | 966M | |
| -35.73% | 900M | |
| -25.74% | 839M |
- Stock Market
- Equities
- 300550 Stock
- Financials Heren Health Co., Ltd.